Germany – Pharmaceutical products – Patent_95.1_Aripiprazol_Abilify (Maintena)
openValue
unstated
Published
26 Oct 2026
Deadline
27 Nov 2026, 09:00 GMT · 31d left · as published, verify on the notice
Type
opportunity · framework
33600000 · Medical equipment, pharmaceuticals & personal careDEA11
Description
Abschluss eines Rabattvertrages für den o. g. Wirkstoff. Es wird eine Rahmenvereinbarung mit einem pharmazeutischen Unternehmen geschlossen. Details dazu sowie zu den teilnehmenden Krankenkassen und den Vertragslaufzeiten entnehmen Sie bitte den Vergabeunterlagen.
Key facts
- Procedure
- open
- Framework agreement
- Yes — a framework or dynamic purchasing system, not a single contract
- Contract period
- 1 Jan 2027 → 31 Dec 2028
- Bids opened
- 27 Nov 2026, 11:00 GMT
- Regime
- publicSector
- Category
- supplies
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- Calendar export — the deadline as a calendar file
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 738584-2026
- First seen
- 26 Oct 2026
- Last updated
- 26 Oct 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/b79d28b9-dda4-4060-8609-777a2bbe009fThe source notice is authoritative — verify deadlines and documents there before bidding.